Melanotan-I
Afamelanotide, MT-I, [Nle4-D-Phe7]-Ī±-MSH, Scenesse, CUV-1647
A synthetic analog of alpha-melanocyte-stimulating hormone that stimulates melanogenesis, increasing skin pigmentation and providing photoprotection against UV radiation.
Active Not Recruiting
PHASE3
NCT04882098
A Study of Guselkumab in Participants With Active Psoriatic Arthritis
Janssen Research & Development, LLC
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
NA
NCT04251052
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
NRG Oncology
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE3
NCT04939428
Study of MK-4482 for Prevention of Coronavirus Disease 2019 (COVID-19) in Adults (MK-4482-013)
Merck Sharp & Dohme LLC
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NA
NCT04612244
The FARAPULSE ADVENT PIVOTAL Trial PFA System vs SOC Ablation for Paroxysmal Atrial Fibrillation
Boston Scientific Corporation
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
PHASE3
NCT05561387
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
SWOG Cancer Research Network
INTERVENTIONAL
Updated Dec 15, 2025
Terminated
PHASE3
NCT00625898
BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab
NSABP Foundation Inc
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
PHASE3
NCT04224493
A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma.
Epizyme, Inc.
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT00433381
Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma
National Cancer Institute (NCI)
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT02315430
Cabozantinib-S-Malate in Treating Patients With Recurrent or Progressive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
National Cancer Institute (NCI)
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT00023751
Surgery With or Without Chemotherapy and Radiation Therapy in TreatingPatients With Stage I Rectal Cancer
Alliance for Clinical Trials in Oncology
INTERVENTIONAL
Updated Dec 15, 2025
Terminated
PHASE3
NCT00005834
S9922 Combination Chemo Plus Filgrastim With or Without Thalidomide in Refractory Multiple Myeloma
SWOG Cancer Research Network
INTERVENTIONAL
Updated Dec 15, 2025
Active Not Recruiting
PHASE2, PHASE3
NCT02152982
Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
National Cancer Institute (NCI)
INTERVENTIONAL
Updated Dec 15, 2025
Active Not Recruiting
PHASE2
NCT02834013
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
National Cancer Institute (NCI)
INTERVENTIONAL
Updated Dec 15, 2025
Terminated
PHASE2, PHASE3
NCT05011513
Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR).
Pfizer
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE3
NCT04955626
To Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of BNT162b2 Boosting Strategies Against COVID-19 in Participants ā„12 Years of Age.
BioNTech SE
INTERVENTIONAL
Updated Dec 15, 2025
Terminated
PHASE3
NCT03381196
A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Non-Hospitalized Participants With Influenza A Infection Who Are at Risk of Developing Complications
Janssen Research & Development, LLC
INTERVENTIONAL
Updated Dec 15, 2025
Active Not Recruiting
PHASE3
NCT04822181
Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)
Novo Nordisk A/S
INTERVENTIONAL
Updated Dec 15, 2025
Active Not Recruiting
PHASE3
NCT05330325
A Research Study to Compare Somapacitan Once a Week With NorditropinĀ® Once a Day in Children Who Need Help to Grow
Novo Nordisk A/S
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
NA
NCT06887647
PT for Montana Children With NMD Using Hippotherapy and the Equine Environment
University of Montana
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
PHASE3
NCT06992427
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
Alliance for Clinical Trials in Oncology
INTERVENTIONAL
Updated Dec 15, 2025